![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/443 | |
A61K 31/47 | |||
A61K 45/06 | |||
A61K 9/16 | |||
A61K 9/20 |
(11) | Number of the document | 3068392 |
(13) | Kind of document | T |
(96) | European patent application number | 14862504.9 |
Date of filing the European patent application | 2014-10-31 | |
(97) | Date of publication of the European application | 2016-09-21 |
(45) | Date of publication and mention of the grant of the patent | 2021-02-24 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/063506 |
Date | 2014-10-31 |
(87) | Number | WO 2015/073231 |
Date | 2015-05-21 |
(30) | Number | Date | Country code |
201361903010 P | 2013-11-12 | US | |
201461929604 P | 2014-01-21 | US | |
201462000659 P | 2014-05-20 | US |
(72) |
SWINNEY, Kelly, Ann, US
HURTER, Patricia, Nell, US
NADIG, David, E., US
SMITH, David, US
THOMAS, Vance, Hayden, US
WARMAN, Martin, Paul, US
|
(73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
(54) | PROCESS OF PREPARING PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES |
PROCESS OF PREPARING PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES |